Harm reduction theory: users' culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users' groups.
This paper discusses the user side of harm reduction, focusing to some extent on the early responses to the HIV/AIDS epidemic in each of four sets of localities-New York City, Rotterdam, Buenos Aires, and sites in Central Asia. Using available qualitative and quantitative information, we present a series of vignettes about user activities in four different localities in behalf of reducing drug-related harm. Some of these activities have been micro-social (small group) activities; others have been conducted by formal organizations of users that the users organized at their own initiative. In spite of the limitations of the methodology, the data suggest that users' activities have helped limit HIV spread. These activities are shaped by broader social contexts, such as the extent to which drug scenes are integrated with broader social networks and the way the political and economic systems impinge on drug users' lives. Drug users are active agents in their own individual and collective behalf, and in helping to protect wider communities. Harm reduction activities and research should take note of and draw upon both the micro-social and formal organizations of users. Finally, both researchers and policy makers should help develop ways to enable and support both micro-social and formally organized action by users.
Friedman
Samuel R
SR
National Development and Research Institutes, Inc., New York, NY, United States. friedman@ndri.org <friedman@ndri.org>
de Jong
Wouter
W
Rossi
Diana
D
Touzé
Graciela
G
Rockwell
Russell
R
Des Jarlais
Don C
DC
Elovich
Richard
R
D000163:Acquired Immunodeficiency Syndrome / Q000453:epidemiology / Q000517:prevention & control / Q000635:transmission; D001118:Argentina / Q000453:epidemiology; D001209:Asia, Central / Q000453:epidemiology; D003466:Cultural Characteristics; D004196:Disease Outbreaks; D006127:Group Structure; D015658:HIV Infections / Q000453:epidemiology / Q000517:prevention & control* / Q000635:transmission; D040261:Harm Reduction; D006801:Humans; D018671:Needle-Exchange Programs; D009426:Netherlands / Q000453:epidemiology; D009519:New York City / Q000453:epidemiology; D010358:Patient Participation; D012657:Self-Help Groups / Q000458:organization & administration*; D012944:Social Support; D012959:Socioeconomic Factors; D015819:Substance Abuse, Intravenous / Q000517:prevention & control* / Q000523:psychology
N Y State J Med. 1966 Sep 15;66(18):2391-408
5222195
AIDS Educ Prev. 2004 Jun;16(3):250-63
15237054
N Engl J Med. 1985 Dec 5;313(23):1476
4058552
Health Educ Q. 1986 Winter;13(4):383-93
3781862
Int J Addict. 1987 Mar;22(3):201-19
3583474
Science. 1988 Nov 11;242(4880):916-9
3187532
JAMA. 1989 Feb 17;261(7):1008-12
2915408
Am J Public Health. 1991 Nov;81(11):1506-17
1951815
JAMA. 1994 Jan 12;271(2):121-7
8264066
Addiction. 1998 Sep;93(9):1403-16
9926546
Cad Saude Publica. 2006 Apr;22(4):741-50
16612428
J Acquir Immune Defic Syndr. 2006 Aug 1;42(4):494-500
16810116
Am J Public Health. 2000 Mar;90(3):352-9
10705851
AIDS. 2002 Dec;16 Suppl 3:S34-41
12685923
Clin Infect Dis. 2003 Dec 15;37 Suppl 5:S338-42
14648443
Clin Infect Dis. 2003 Dec 15;37 Suppl 5:S343-7
14648444
Clin Infect Dis. 2003 Dec 15;37 Suppl 5:S348-52
14648445
Ann Intern Med. 1985 Nov;103(5):755-9
4051350